Suppliers / Pranami Drugs

Pranami Drugs

India Updated 9 July 2026

Pranami Drugs is an API manufacturer based in India. It holds one active US drug master file. Customs aggregates show $490K of exports covering 16 molecules to 3 destinations in 2025.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Miconazole US FDA 1

Also appears on these molecule pages

Miconazole API

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $7K 1
2025 Not reported $490K 3
2024 Not reported $162K 3
2023 Not reported $38K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Pranami Drugs

Does Pranami Drugs hold a US DMF or a CEP?
Pranami Drugs holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Pranami Drugs make?
1 molecule is on record against Pranami Drugs, including Miconazole. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Pranami Drugs comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Olon shares 1 molecule Quimica Sintetica shares 1 molecule Erregierre shares 1 molecule FDC Limited shares 1 molecule Janssen Pharmaceutica shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts